1-Al-Shamary , A. and Ibraheem , M. N.(2011). Hypercholesterolemia and Acute Myocardial Infarction. Iraqi J. Comm. Med., Apr 9:125-127.
2-Abifadel, M.;Varret, M.; Rabes, JP.; et al. (2003).Mutations in PCSK9 cause autosomal dominant hypercholesterolemia . Nat Genet. 34(2):154-156.
3-Fouchier , S.W.; Kastelein ,J.J.P.; Defesche,J.C.(2005).Update of the molecular basis of familial hypercholesterolemia in the Netherlands . Human Mutation. vol. 26 , no. 6 , p: 550-556.
4-Leighi, S.E.A.; Foster, H.; Whittall, R.A.; Hubbart, C.S.; Humphries, S . E . (2008) . Update and analysis of the university College London low density lipoprotein receptor familial hypercholesterolemia database . Annals of Humman Genetics.Vol.72, No 4, pp. 485-498 .
5-Martínez-Martínez, I., Montoro-García, S., Lozada-Ramírez, J. D., Sánchez-Ferrer, Á., & García-Carmona, F. (2007). A colorimetric assay for the determination of acetyl xylan esterase or cephalosporin C acetyl esterase activities using 7-amino cephalosporanic acid, cephalosporin C, or acetylated xylan as substrate. Analytical Biochemistry, 369(2), 210–217.
6-Ahmadi, S.-A., Boroumand, M.-A., Gohari-Moghaddam, K., Tajik, P., & Dibaj, S.-M. (2008). The impact of low serum triglyceride on LDL - cholesterol estimation. Archives of Iranian Medicine, 11(3), 318–321.
7-Dong, J., Guo, H., Yang, R., Li, H., Wang, S., Zhang, J., & Chen, W. (2011). Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC. Journal of Lipid Research, 52(2), 383–388.
8-Salazar, LA.; Hirata, MH.; Forti, N.; Diament, J.; Giannini, SD; Issa, J. ; Hirata , RDC . (2000) . II intron 15 polymorphism at the LDL Receptor gene is associated with differences in serum Lipid concentrations in individuals with low and high risk for Coronary Artery disease from Brazil.293: 75-88.
9-Farrokhi, E.; Shayestesh, F.; Asadi, S.; Roghani, F.;Ghatreh, K.; Hashemzadeh , M.( 2008 ). Molecular characterization of Iranin Patients with possible familial hypercholesterolemia.Ind.J. Clin Biochem. 26 (3) : 244-248.
10-Vander, S.; Widmaier, L.; Eric, K.; and Hershel, R.(2004). Human physiology the mechanism of body function , 9th ed published by Mc Graw -Hill companies NewYork,p .442.
11-Dineshkumar, B.; Analava, M. and Manjunatha, M. (2010). studies on the anti – diabetic and hypolipidemic potentials in type 2 Diabetic patients " . International Jonrnal of Advances in pharmaceutical sciences, 1: 75 -85 .
12-Grundy, S.M. (2009). Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome,The American journal of cardiology, 81: 18-25 .
13-Bronk, R.(1999). Human metabolism functional diversity and. Integration .4th ed.Addison Wesley Longman Limited., pp.228.
14-Morrison , A. ; Hokanson, J. E.; Venge , P.(2009). The independent relationship between triglycerides and coronary heart Disease . Vasc. Health Risk Manag . 5 : 89 – 95 .
15-Labreuche, J.; Touboul , P. J. and Amarenco , P. (2009) . Plasma triglyceridelevels and risk of stroke and carotid atherosclerosis : a systematic review of the epidemiological studies . Atherosclerosis .203 : 331 – 345 .
16-Hossein, M.D. (2014) . A survey of the Relationship between Serum Cholesterol and Triglyeride to Glaucoma : A Case control study . Medically . Vol. (10) . pp : 334-400 .
17-Coyle, E.F. (2000). Physical activity as metabolic stressors". Am. Clin.Nutr. Suppl. 72: 512-520 .
18-Gygi, F. R. (2014). Museum objects experiencing the properties of things, Dudley, Sandra H. (ed.). Material Religion, 10(1),115–116.
19-Rifai, N.; Bachorik, P. and Albers, J. (2004). Lipids, lipoproteins and Apo proteins . In : Tietz Fundamentals of clinical chemistry. Burtis CA and Ashwood ER ( eds ) . 5th ed . W.B. Saunders Company, Philadelphia, p : 462-493 .
20-Marta, M.M ; Duarte, F. ; Joao, B. ; Rafael, N. ; Thiago, D. ; Ivana, B. M . ; Maria , R .C . ( 2009 ) . Association between ischemia modified albumin , Lipids and inflammation biomarkers in Patients with hypercholesterolemia.Clinibiochem , p : 666-671.
21-Lloyd-Jones, D. M. (2014). Niacin and HDL Cholesterol - Time to Face Facts. New England Journal of Medicine, 371(3), 271–273 .
22-Guytun, C. and Hall, T. (2010). Text book of medical physiology".10 th ed . W. B . Sanders company . New York . p :774-789 .
23-Fruchart, J.C. and Packard, C.J. (2007). Is cholesterol the major lipoprotein risk factor in coronary heart disease ? " A Franco Scottish overview . Curr Med . Res . Opin . 13 : 603 – 616.
24-Thibodeau , G . A. and Patton , K . T .( 2003) .Anatomy and Physiology 5th ed . Mosby , Inc. , p : 925 – 927 .
25-Brewer, H. B. (2004). Focus on high density lipoproteins in reducing Cardiovascular risk. Am. Heart. J; 148: 14-18 .
26-Murray, R. K.; Granner, D. K.; Mayes, P.A.; (2010) Harpers. Biochemistry : lipid transport and strorage . 25th ed by mays A Appleton and lange, Lebanon. By typopress ,27: 268-282.
27-Fatimah, M. Y. ; Mohd, H.S. ; Muhammad, F. H. ; Siti, R.H. (2016 ) . Lipid profile of the Coronary Heart Disease (CHD) patients Admitted in a hospital in Malaysia. Journal of Applied pharmaceutical Science .Vol.6 (50) . p : 137-142 .
28-Nayab, B. ; Saeed, A.N. (2012) . Literature Review : Cardiovascular Disorders and Lipidprofile . Atherosclerosis , Vol.(38) , p : 205-230 .
29-Carmena, R.; Duriez, P.; Fruchart, JC.(2004).Atherogenic lipoprotein. Particles in Atherosclerosis. Circulation , Vol. (109) , p : 7-1112 .
30-Mills, P. ; Chong , G. ; Ghement, I. ; Singh, S. ; Guyatt, G. (2011). Efficacy and safety of statin treatment for cardiovascular disease a network meta- analysis of 170 . 255 patients from randomized trials QJM : Journal of the Association of physicions . 104 : ( 2 ) : 109-24 .